Ligand Pharmaceuticals LGND
NASDAQ LGND
$302.96 +0.22 (+0.07%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ligand Pharmaceuticals (LGND) Cash & Current Investments (2010 - 2026)

Updated

Ligand Pharmaceuticals' Cash & Current Investments came in at $1.36 billion for Q2 2026, up 454.1% from $245.02 million a year earlier and up 74.2% from the prior quarter.

Analysis

Ligand Pharmaceuticals (LGND) Cash & Current Investments (2010 - 2026) Analysis & Trends

At the end of FY2025, Ligand Pharmaceuticals' Cash & Current Investments was $733.52 million, up 186.3% from FY2024.

  • Cash & Current Investments carries a five-year compound annual growth rate of 12.3% (FY2020 to FY2025).
  • Going back by year, Cash & Current Investments was $256.17 million in FY2024 (+50.4%), $170.31 million in FY2023 (-19.6%), $211.87 million in FY2022 (-37.9%) and $341.11 million in FY2021 (-17.0%).
  • The Q2 2026 figure represents the highest quarterly Cash & Current Investments since Q1 2019.
  • Year-over-year, Cash & Current Investments has increased for five consecutive quarters, with growth averaging 144.6% over the last eight quarters.
  • The fastest year-over-year change in Cash & Current Investments over five years came in Q2 2026 (growth of 454.1%), and the weakest in Q3 2022 (a decline of 62.4%).
  • Business Quant data shows LGND's Cash & Current Investments at $779.41 million (Q1 2026), $733.52 million (Q4 2025) and $664.52 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 Ligand Pharmaceuticals 6.03 Bn 2.50 Bn - 1.36 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.36 Bn
Mar 31, 2026 779.41 Mn
Dec 31, 2025 733.52 Mn
Sep 30, 2025 664.52 Mn
Jun 30, 2025 245.02 Mn
Mar 31, 2025 208.90 Mn
Dec 31, 2024 256.17 Mn
Sep 30, 2024 219.64 Mn
Jun 30, 2024 226.93 Mn
Mar 31, 2024 310.59 Mn
Dec 31, 2023 170.31 Mn
Sep 30, 2023 190.50 Mn
Jun 30, 2023 219.04 Mn
Mar 31, 2023 282.67 Mn
Dec 31, 2022 211.87 Mn
Sep 30, 2022 121.41 Mn
Jun 30, 2022 147.94 Mn
Mar 31, 2022 204.00 Mn
Dec 31, 2021 341.11 Mn
Sep 30, 2021 323.21 Mn
API Access

Ligand Pharmaceuticals Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=LGND&period=max&api_key=YOUR_API_KEY